Moorfields Eye Hospital has been given approval to carry out a trial into retinal stem cell treatment for Stargardt's disease. The Medicines and Healthcare Products Regulatory Agency agreed to the trials, which are due to start in the next few months with 12 patients. They will investigate the safety of using retinal cells derived from human embryonic stem cells to treat people with advanced Stargardt's disease; a form of macular degeneration that causes disabling sight loss in young people.Learn more about Stem cell trial is given go-ahead at Moorfields www.opticianonline.net
